Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OXACILLIN vs OXALIPLATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OXACILLIN vs OXALIPLATIN: Safety Overview

Metric OXACILLIN OXALIPLATIN
Total FAERS Reports 538 56,406
Deaths Reported 89 6,501
Death Rate 16.5% 11.5%
Hospitalizations 254 21,980
Average Patient Age 46.9 yrs 61.5 yrs
% Female Patients 44.9% 42.1%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 28, 2011
Manufacturer Eugia US LLC Camber Pharmaceuticals, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Discontinued